Phosphodiesterase 4 inhibitors, structurally unrelated to Rolipram, as promising agents for the treatment of asthma and other pathologies

European Journal of Medicinal Chemistry

Volumn 35, Issue 5, 2000, Pages 463-480

  Dal Piaz, Vittorio ^a   Giovannoni, Maria Paola ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

Author keywords

Asthma; Autoimmune diseases; Chemical classification; Chronic pulmonary obstructive disease; Phosphodiesterase 4 inhibitors

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; CORTICOSTEROID; CYCLIC AMP; CYCLIC GMP; CYTOKINE; NITRAQUAZONE; PHOSPHODIESTERASE IV INHIBITOR; REACTIVE OXYGEN METABOLITE; ROLIPRAM; XANTHINE DERIVATIVE;

ASTHMA; AUTOIMMUNE DISEASE; BRONCHODILATATION; BRONCHUS MUSCLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CYTOKINE PRODUCTION; DRUG STRUCTURE; ENZYME LOCALIZATION; HEADACHE; HUMAN; IMMUNOCOMPETENT CELL; MEDIATOR RELEASE; NAUSEA; NONHUMAN; REVIEW; SECOND MESSENGER; VOMITING;

EID: 0000203434     PISSN: 02235234     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0223-5234(00)00179-3     Document Type: Review

References (153)

1. Norman P. Exp. Opin. Ther. Patents. 9:1999;1101-1117.
2. Burnouf C., Pruniaux M.P., Szilagyi C.M. Bristol J.A. Annual Reports in Medicinal Chemistry. 1998;91-125 Academic Press, San Diego.
3. Bolger G., Michaeli T., Martins T., Souness J.E., Rao S. Cell. Signal. 9:1997;2-13.
4. Engels P., Fichtel K., Lubbert H. FEBS Lett. 350:1994;291-295.
5. Conti M., Swinnen J.V., Tsicalas K.E., Jin S.L.C. Adv. Second Messenger Phosphoprotein Res. 25:1992;87-99.
6. Palacios J.M., Beleta J., Segarra V. Il Farmaco. 50:1995;819-827.
7. Cavalla D., Frith R. Curr. Med. Chem. 2:1995;561-572.
8. Lombardo L.J. Curr. Pharm. Des. 1:1995;255-268.
9. Palfreyman M.N., Souness J.E. Ellis G.P, Luscombe D.K. Progress in Medicinal Chemistry. 1996;1-52 Elsevier, Amsterdam.
10. Raeburn D., Karlsson J.A. J. Pharm. Pharmacol. 49:1997;19-24.
11. Norman P. Exp. Opin. Ther. Patents. 8:1998;771-784.
12. Karlsson J.A., Aldous D. Exp. Opin. Ther. Patents. 7:1997;989-1003.
13. Schneider H.H., Schmiechen R., Brezinski M., Seidler J. Eur. J. Pharmacol. 127:1986;105-115.
14. Barnette M.S., Christensen S.B., Essayan D.M., Grous M., Prabhakar U., Rush J.A., Kagey-Sobota A., Torphy T.J. J. Pharmacol. Exp. Ther. 284:1998;420-426.
15. Norman P. Current Opinion in Anti-inflammatory & Immunomodulatory Investigational Drugs. 1:1999;48-50.
16. William Harvey Research Conferences: "PDE inhibitors: drugs with an expanding range of therapeutic uses". Nice, December 1-3, 1999.
17. Beavo J.A. Physiol. Rev. 75:1995;725-748.
18. Torphy T.J. Am. Respir. Crit. Care M. 157:1998;351-370.
19. Nishi T., Tabusa F., Tanaka T., Ueda H., Shimizu T., Kanabe T., Kimura Y., Nakagawa K. Chem. Pharm. Bull. 31:1983;852-860.
20. Watanabe K., Nakase H., Kimura K. Arzneim.-Forsch. 36:1986;1022-1024.
21. Terrett N.K., Bell A.S., Brown D., Ellis P. Bioorg. Med. Chem. Lett. 6:1996;1819-1824.
22. Alousi A.A., Canter J.M., Montenaro M.J., Fort D.J., Ferrari R.A. J. Cardiovasc. Pharmacol. 5:1983;792-803.
23. Vernon M.W., Heel M.W., Brodgen R.N. Drugs. 42:1991;997-1017.
24. Feldman A.M., Bristow M.R., Parmley W.W., Carson P.E., Pepine C., Gilbert E.M., et al. N. Engl. J. M. 329:1993;149-155.
25. Van Meel J.C.A. Arzneim.-Forsch. 35:1985;284-288.
26. Nemoz G., Prigent A.F., Moueqqit M., Fougier S., Macovschi O., Pacheco H. Biochem. Pharmacol. 34:1985;2997-3000.
27. Barnett M.S. Jucker F. Progress in Drug Research Vol. 53. 1999;1193-1229 Birkhauser Verlag, Basel.
28. Weinberger S.E. N. Engl. J. M. 328:1993;1389-1397.
29. Whelan C.J. Drugs Today. 32:1996;295-311.
30. Jeffery P.K. Am. Rev. Respir. Dis. 143:1991;1152-1158.
31. Laitinen L.A., Laitinen A., Haahtela T. Am. Rev. Respir. Dis. 147:1993;697-704.
32. Bradley B.L., Azzawi M., Jacobson M.J. Allergy Clin. Immunol. 88:1991;661-674.
33. Bousquet J., Chanez P., Vignola A.M., Lacoste J.Y., Michel F.B. Crit. Care M. 150:1994;S33-S38.
34. McFadden E.R. Jr., Gilbert I.A. N. Engl. J. M. 327:1992;1928-1937.
35. Barnes P.J. Eur. Respir. J. 5:1992;11226-11236.
36. Lipworth B.J. Pharmacol. Ther. 58:1993;173-209.
37. Martindale. The complete drug reference, 32nd Edition. 1999;758-761 Pharmaceutical Press, London.
38. Sears M.R., Taylor D.R., Print C.G., Lake D.C., Li Q., Flannery E.M., et al. Lancet. 336:1990;1391-1396.
39. Barnes P.J., Chung K.F. Trends Pharmacol. Sci. 13:1992;20-23.
40. Torphy T.J., Livi J.P., Balcarek White J.R., Chilton F.H., Undem B.J. Strada S.J, Hidaka H. Advances in Second Messenger and Phosphoprotein Research. 25:1992;289 Raven Press, NY.
41. Barnes P.J., Rodger I.W., Holgata S.T. Asthma - Basic Mechanism and Clinical Management. 1989;Academic Press.
42. Kay A.B. Eosinophils, Allergy and Asthma. 1990;Blackwell Scientific Publications.
43. Holgata S.T. The role of Inflammatory Process in Airway Hyper-responsiveness. 1989;Blackwell Scientific Publications.
44. Shahid M., Nicholson C.D. Naunyn-Schimiedeberger's Arch. Pharmacol. 342:1990;698-705.
45. Norman P. Drugs News Persp. 11:1998;431-437.
46. Norman P., Financial Times Pharmaceuticals Management Reports (1999).
47. Elliot M.J., Maini R.N., Feldmann M., Kalden J.R., Antoni C., Smolen J.S., et al. Lancet. 344:1994;1105-1110.
48. Nyman U., Mussener A., Larsson E., Lorentzen J. Clin. Exp. Immunol. 108:1997;415-419.
49. Souness J.E., Foster M. Drugs. 1:1998;541-553.
50. Sommer N., Loschmann P.A., Northoff G.H., Weller M., Steinbrecher A., Steinbach J.P., et al. Nat. M. 1:1995;244-248.
51. Jung S., Zielasek J., Kellner G., Donhauser T., Toyca K., Hartung H.P. J. Neuroimmunol. 68:1996;1-11.
52. Genain C.P., Roberts T., Davis R.L., Nguyen M.H., Uccelli A., Faulds D., et al. Proc. Natl. Acad. Sci. USA. 92:1995;3601-3605.
53. Ekholm D., Hemmer B., Gao G., Vergelli M., Martin R., Manganiello V. J. Immunol. 159:1997;1520-1529.
54. Rott O., Cash E., Fleischer B. Eur. J. Immunol. 23:1993;1745-1751.
55. Liang L., Beshay E., Prud'homme J.I. Diabetes. 47:1998;570-575.
56. Carcillo J.A., Herzer W.A., Mi Z., Thomas M.J., Jackson E.K. J. Pharmacol. Exp. Ther. 279:1996;1197-1204.
57. Cardelus I., Gras J., Jauregui J., Llenas J., Palacios J.M. Eur. J. Pharmacol. 299:1996;153-159.
58. Staudinger T., Presterl E., Graninger W., Locker G.J., Knapp S., Laczika K., et al. Intensive Care M. 22:1996;888-893.
59. Reimund J.M., Dumont D., Muller C.D., Kenney J.S., Kedinger M., Baumann R., Piondron P., Duclos B. Gut. 40:1997;475-480.
60. Gantner F., Kusters S., Wendel A., Hatzlmann A., Schudt C., Tiegs G.J. Pharmacol. Exp. Ther. 280:1997;53-60.
61. Miyamoto K., Waki Y., Horita T., Kasugai S., Ohya K. Biochem. Pharmacol. 54:1997;613-617.
62. Rascon A. Acta Cientifica Venezolana. 48:1997;145-153.
63. Pauwels R. Life Sci. 52:1993;2171-2179.
64. Frew A.J., Holgate S.T. Drugs. 46:1993;847-862.
65. Bowler S.D., Mitchell C.A., Armstrong J.G. Eur. Respir. Dis. 70:1987;280-283.
66. Eason J., Makowe H.L. J. Respir. M. 83:1989;219-226.
67. Barnes P.J., Pauwels R.A. Eur. Respir. J. 7:1994;579-591.
68. Brenner M., Berkowitz R., Marshall N., Strunk R.C. Clin. Allergy. 18:1988;143-150.
69. Barnes P.J. Am. J. M. 85:(Suppl. 1B):1988;64-70.
70. Persson C.G.A., Andersson K.E., Kjellin G. Life Sci. 38:1986;1057-1072.
71. Sato J., Nakata H., Owada E., Kikuta T., Umetsu M., Ito K. Eur. J. Clin. Pharmacol. 44:1993;295-298.
72. Persson C.G.A., Pauwels R.A. Page C.P, Barnes P.J. Handbook of Experimental Pharmacology. 1991;207-225 Springer Verlag, Berlin.
73. Barnes P.J., Mode of action of Theophylline: a multiplicity of actions, Intern. Congr. Symp. Series 126 (1988) 39-45.
74. Bergstrand H. Eur. Respir. Dis. 61:(Suppl. 109):1980;37-44.
75. Polson J.B., Kazanowsky J.J., Goldman A.L., Szentivany A. Clin Exp. Pharmacol. Physiol. 5:1978;535-539.
76. Handslip P.D.J., Dart A.M., Davies B.T.I. Thorax. 36:1981;741-744.
77. Jenne J.W. Chest. 92:1981;7S-14S.
78. Cusley M.J., Tattersfield A.E., Holgate S.T. Am. Rev. Respir. Dis. 129:1984;380-384.
79. Bjork T., Gustafson L.E., Dahlen S.E. Am. Rev. Respir. Dis. 145:1992;1087-1091.
80. Mann J.S., Holgate S.T. Brit. J. Clin. Pharmacol. 19:1985;85-92.
81. Church M.K., Featherstone R.L., Cushley M.J., Mann J.S., Holgate S.T. J. Allergy Clin. Immunol. 78:1986;670-675.
82. Howell R.E., Muehsam W.T., Kinnier W.J. Life Sci. 46:1990;563-568.
83. Kips J.C., Tavernier J.H., Pelemam R.A., Joos G.F., Pawels R.A. Int. Arch. Allergy Appl. Immunol. 99:1992;478-481.
84. Lilly C.M., Sandhu J.S., Ishizaki A., Harada H., Yonemaru M., Larrick J.W., et al. Am. Rev. Respir. Dis. 139:1989;1361-1368.
85. Barnes P.J., Pauwels R.A. Eur. Respir. J. 7:1994;579-591.
86. Souness J.E., Rao S. Cell. Signal. 9:1997;227-238.
87. Glaser T., Traber J. Agents Action. 15:1984;341-348.
88. Polymeropoulos E.E., Hofgen N. Quant. Struct.-Act. Relat. 16:1997;231-234.
89. Lowe III J.A., Archer R.L., Chapin D.S., Cheng J.B., Helwey D., Johonson J.C., et al. J. Med. Chem. 34:1991;624-628.
90. Wilhelm R.S., Chin R.L., Devens B.H., Alvarez R., Int. Pat Appl. WO 93 19068; Chem. Abst. 120 (1994) 164213.
91. Wilhelm R.S., Fatherlee P.R., Chin R.L., Int. Pat. Appl. WO 94 22852; Chem. Abstr. 122 (1995) 55901.
92. Matsuura A., Ashizawa N., Agawura R., Kumonana T., Hase T., Shimizu C., Kinihara T., Kobayashi F. Biol. Pharm. Bull. 17:1994;498-503.
93. Suzuki F., Kurada T., Kawanita T., Manabe H., Kitamura S., Ohmori K., et al. J. Med. Chem. 35:1992;4866-4874.
94. Luond R., Pombo-Villar E., Int. Pat. Appl. WO 97 18208; Chem. Abstr. 127 (1997) 50650.
95. Hisamichi H., Takayama K., Iwata M., Kubata H., Kawano N., Aoki M., Isomura Y., 215th ACS National Meeting, Dallas 215 (1998) MEDI 49.
96. Szelenyi S.K., Poppe H., Dent G., Magnussen H., Rabe K.F. Am. J. Resp. Crit. Care M. 156:1997;A624.
97. Wilhelm R., Loe B., Alvarez R., Devens B., Fong A., P-32, 8th RSC-SCI Medicinal Chemistry Symposium, Cambridge, UK, 10-13 September, 1995.
98. Dal Piaz V., Giovannoni M.P., Castellana C., Palacios J.M., Beleta J., Doménech T., Segarra V. J. Med. Chem. 40:1997;1417-1421.
99. Dal Piaz V., Giovannoni M.P., Castellana C., Palacios J.M., Beleta J., Doménech T., Segarra V. Eur. J. Med. Chem. 33:1998;789-797.
100. Vinick F.J., Saccomano N.A., Koe B.K., Nielsen J.A., Williams I.H., Thadeio P.F., et al. J. Med. Chem. 34:1991;86-89.
101. Shimazaki N., Watanabe S., Sawada A., Hemmi K., UK Pat Appl. GB-2291422 (1996); Chem Abstr. 125 (1996) 10857.
102. Shimazaki N., Sawada A., Watanabe S., Int. Pat. Appl. WO 97 24355; Chem. Abstr. 127 (1997) 149156.
103. Beasley S.C., Cooper N., Gowers L., Gregory J.P., Haughan A.F., Hellewell P.G., et al. Bioorg. Med. Chem. Lett. 8:1998;2629-2634.
104. Dyke H.J., Montana J.G., Lowe C., Kendall H.J., Hannah J., Sabin V.M., Int. Pat. Appl. WO 97 44036 (1998); Chem. Abstr. 128 (1999) 48146.
105. Miyamoto K., Kurita M., Ohmae S., Sakai R., Sanae F., Takagi K. Eur. J. Pharmacol. 267:1994;317-322.
106. Miyamoto K., Yamamoto Y., Kurita M., Sakai R., Konno K., Sanae F., et al. J. Med. Chem. 36:1993;1380-1386.
107. Sakai R., Conno K., Yamamoto Y., Sanae F., Takagi T., Hasegawa T., et al. J. Med. Chem. 35:1992;4039-4044.
108. Miyamoto K., Sakai R., Yamamoto Y., Konno K., Sanae F., Hasegawa T., Takagi K. J. Pharm. Pharmacol. 44:1992;888-892.
109. Takagi K., Hasegawa T., Kuzuya T., Ogawa K., Watanabe T., Satake K., et al. Jpn. J. Pharmacol. 46:1988;373-378.
110. Sawanishi H., Suzuki H., Yamamoto S., Waki Y., Kasugai S., Ohya K., et al. J. Med. Chem. 40:1997;3248-3253.
111. Connor D.T., Unangst P.C. Wolff M.E. Burger's Medicinal Chemistry and Drug Discovery, 5th Edition. 1996;535-538 John Wiley and Sons Inc, NY.
112. Persson C.G.A., Kjellin G. Acta Pharmacol. Toxicol. 49:1981;313-316.
113. Lunell E., Svedmyr N., Andersson K.E., Persson C.G.A. Eur. J. Clin. Pharmacol. 22:1982;395-402.
114. Grassi C., Casali L., Rampulla C., Rossi A. Int. J. Clin. Pharmacol. Ther. Toxicol. 18:1980;518-522.
115. Li T., Volpp K.T., Applebury M.L. Proc. Natl. Acad. Sci. USA. 87:1990;293-297.
116. Shahid M., van Amsterdam R.G.M., de Boer J., den Berge R.E., Nicholson C.D., Zaagsma J. Br. J. Pharmacol. 104:1991;471-477.
117. Nicholson C.D., Jackman S.A., Wilke R. Br. J. Pharmacol. 97:1989;889-897.
118. Cortjio J., Bou J., Beleta J., Cardelus I., Llenas J., Morcillo E., Gristwood R.W. Br. J. Pharmacol. 108:1993;562-568.
119. Hatzelmann A., Tenor H., Schudt C. Br. J. Pharmacol. 114:1995;821-831.
120. Lowe Iii J.A., Cheng J.B. Drugs Future. 17:1992;799-807.
121. Manzini S., Meini S., Giachetti A., Beani L., Borea P.A., Antonelli T., Ballati L., Bacciarelli C. Arzneim.-Forsch. 40:1990;1205-1213.
122. Buckle D.R., Arch J.R.S., Connolly B.J., Fenwick A.E., Fostre K.A., Murray K., et al. J. Med. Chem. 37:1994;476-485.
123. Beleta J., Bou J., Miralpeix M., Domenech T., Berga P., Gristwood R.W., Palacios J.M., 3rd International Conference on Cyclic Nucleotide Phosphodiesterase: from Genes to Therapies, July 18-21, 1996, Glasgow, UK.
124. Norman P. Current Opinion in Anti-inflammatory & Immunomodulatory Investigational Drugs. 1:1999;48-50.
125. Lauria X., Ferrer P., ALA/ATS (1997) International Conference, San Francisco, USA, May 16-21.
126. Montana J.G., Cooper N., Dyke H.L., Gowers L., Gregory J.P., Hellewell P.G., et al. Bioorg. Med. Chem. Lett. 8:1998;2925-2930.
127. Agostini O., Bacciarelli C., Bonacchi G., Fedi M., Manzini S., US Pat. 5, 314, 890 (1994); Chem. Abstr. 116 (1992) 151442.
128. Manzini S., Fedi M., Bonacchi G., Agostino O. Drugs Future. 15:1990;228-229.
129. Ward P.A., Clissold S.P. Drugs. 34:1987;50-97.
130. Strieter R.M., Remick D.G., Ward P.A., Spengler R.N., Lynch Iii J.P., Larrick J., Kunken S.L. Biochem. Biophys. Res. Comm. 155:1988;1230-1235.
131. Buckle D.R., Arch J.R.S., Connoly B.J., Fenwick A.E., Foster K.A., Murray K.J., et al. J. Med. Chem. 37:1994;476-485.
132. Souness J.E., Scott L.C., Tonikinson A., Giembycz M.A., Raeburn D. Br. J. Pharmacol. 108:1993;71.
133. Kawasaki A., Hoshino K., Osaki R., Mizushima Y., Yano S. J. Asthma. 29:1992;245-252.
134. Cavalla D., Hofer P., Gehrige A., Wintergest P., Int. Pat. Appl. WO 95 00516 (1995); Chem. Abstr. 122 (1995) 239459.
135. Vitse O., Laurent F., Pocock T.M., Benezech V., Zanik L., Elliot K.R.F., et al. Bioorg. Med. Chem. Lett. 7:1999;1059-1065.
136. Davies G.E. J. Pharm. Pharmacol. 25:1973;681-689.
137. Cavalla D., Gale D.D. Drug News Perspect. 10:1997;470-476.
138. Gale D.D., Landells L.J., Spina D. Am. Resp. Crit. Care. M. 159:1999;A611.
139. Aldous D., Bower S., Escott K.J., Geiger L.E., Iqbal S., Mariucci M. et al., 15th EFMC Int. Symp. Med. Chem. (1997) September 6-10, Edimburgh, Abstr. P337.
140. Stafford J.A., Feldman P.L., Marron B.E., Schoenen F.J., Valvano N.L., Unwalla R.J., et al. Bioorg. Med. Chem. Lett. 4:1994;1855-1859.
141. Fisher R., Braunlich G., Mohrs K.H., Hanko R., Butler-Ransohoff J.E., Es-Sayed M. et al., Eur. Pat. Appl. EP-623607 (1994); Chem. Abstr. 122 (1995) 160466.
142. Braunlich G., Schneider S., Es-Sayed M., Henning R., Sperzel M., Fisher R. et al., Int. Pat. Appl. WO 9802440; Chem. Abstr. 128 (1998) 140689.
143. Dyke H., Kendall H.J., Lowe C., Montana J.G., Int. Pat. Appl. WO 97 20833; Chem. Abstr. 127 (1997) 108836.
144. Dyke H., Lowe C., Montana J.G., Kendall H.J., Sabin V.J., Int. Pat Appl. WO 97 44337; Chem. Abstr. 128 (1999) 48134.
145. McGarry D.G., Regan J.R., Voltz F.A., Hulme C., Moriarty K.J., Djurich S.W., et al. Bioorg. Med. Chem. Lett. 7:1999;1131-1139.
146. Amschler H., Beer T., Gutterer B., Flockerzi D., Martin T., Tibaut U. et al., Int. Pat. Appl. WO 96 36625, Chem. Abstr. 126 (1997) 74737.
147. Oshima E., Matsusaki T., Iida K., Ichimura M., Int. Pat Appl. WO 98 22452; Chem. Abstr. 129 (1999) 16048.
148. Nakazato N., Oshima E., Kawakita T., Yanagawa K., Ichimura M., Manbe H., Sato S., Kakai Tokyo Koho JP 10147585 A2; Chem. Abstr. 129 (1999) 5487.
149. Marfat A., Int. Pat Appl. WO 98 09961; Chem. Abstr. 128 (1999) 217368.
150. Duplantier A.J., Andresen C.J., Cheng J.B., Cohan V.L., Decker C., Di Capua F.M., et al. J. Med. Chem. 41:1998;2268-2277.
151. Pascal Y., Andrianjara C.R., Auclair E., Avenel N., Bertin B., Calvet A., et al. Bioorg. Med. Chem. Lett. 10:2000;35-38.
152. Collado M.C., Beleta J., Martinez E., Miralpeix M., Domenech T., Palacios J.M., Hernandez J. Brit. J. Pharmacol. 123:1998;1047-1054.
153. Leroux F., van Keulen B.J., Daliers J., Pommery N., Hènichart J.P. Bioorg. Med. Chem. Lett. 7:1999;509-516.